EXAS vs FA · rev $2.76B vs P/E 318, rev $860.2M
EXACT Sciences Corporation (EXAS) versus First Advantage Corp (FA) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
First Advantage Corp (FA) is a specialty business services company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported FA revenue for 2024-12-31 was $860.2M. Net income was -$110.3M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. FA currently screens at market cap $2.72B and trailing P/E 317.6.
EXAS currently screens at market cap $20.03B. FA currently screens at market cap $2.72B and trailing P/E 317.6.
Not investment advice. Open the EXAS and FA stock pages for the full models.
Not investment advice.